000
| 01732nam 2200385zi 4500 |
---|
001 | 9.912975 |
---|
003 | CaOODSP |
---|
005 | 20221107182702 |
---|
006 | m o d f |
---|
007 | cr mn||||||||| |
---|
008 | 220630t20222022onc o f000 0 eng d |
---|
020 | |a9780660443614 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aHP40-314/1-2022E-PDF |
---|
245 | 00|aPrioritization guide for assessing the need for economic evidence. |
---|
250 | |aVersion 1.0 |
---|
264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2022. |
---|
264 | 4|c©2022 |
---|
300 | |a1 online resource (9 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aCover title. |
---|
500 | |a"February 2022." |
---|
500 | |a"Protecting and empowering Canadians to improve their health." |
---|
500 | |aAt head of title: National Advisory Committee on Immunization (NACI). |
---|
500 | |aIssued also in French under title: Guide sur l'établissement des priorités relatives aux données économiques. |
---|
520 | |a"User guide: Burden of disease -- Proposed benefit -- Overall assessment of need for economic evidence"--Pages 7-8. |
---|
650 | 0|aVaccination|xEconomic aspects|zCanada. |
---|
650 | 0|aVaccines|xEconomic aspects|zCanada. |
---|
710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
---|
710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
---|
775 | 08|tGuide sur l'établissement des priorités relatives aux données économiques.|w(CaOODSP)9.912974 |
---|
856 | 40|qPDF|s241 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-314-1-2022-eng.pdf |
---|